Category Archives: Proton Pump Inhibitors

Featured Stories

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Proton Pump Inhibitors Raise Infection Risk in Cirrhosis Patients

Proton Pump Inhibitors (PPIs) such as Prilosec, Aciphex, Prevacid, and Protonix, raise infection risks in cirrhosis patients, according to a new study that found the risk for serious infections affects patients with decompensated cirrhosis. PPI users suffer from a 66 … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Meta-Analysis Finds Proton Pump Inhibitors Increase Risk of C. Difficile-Associated Diarrhea by 69%

A newly-published study has again shown that the use of popular heartburn drugs known as proton pump inhibitors can increase the likelihood that a person will develop Clostridium difficile-associated diarrhea.  The authors of the study, which appears in the American … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Study Finds “Robust” Risk of C. difficile with Proton Pump Inhibitors, other Heartburn Drugs

A new study has found that taking acid reducing drugs, including proton pump inhibitors, can significantly increase the risk for Clostridium difficile (C. difficile) infection. The lead author of the study, which involved a meta-analysis of 30 separate studies, characterized … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

PPI Side Effect Warnings for Fractures, Hypomagnesaemia Issued in U.K.

U.K. regulators issued two warnings this week regarding serious Proton Pump Inhibitor (PPI) side effects. According to the Medical and Healthcare Products Regulatory Agency (MHRA), recent studies indicated a link between long-term use of PPIs and fractures of the hip, … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Health Canada Warns PPIs May Cause C. Diff-Associated Diarrhea

Health Canada is warning Canadians that prescription stomach antacids called proton pump inhibitors (PPIs) may cause Clostridium difficile–associated diarrhea (CDAD). CDAD is a potentially serious gastrointestinal infection. C. diff is bacterium that can cause diarrhea and may lead to more … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

FDA Says Proton Pump Inhibitors May Cause C-difficile Diarrhea

Using popular heartburn drugs called proton pump inhibitors (PPIs) could put some users at risk of contracting Clostridium difficile–associated diarrhea (CDAD), a potentially serious gastrointestinal infection. In a Drug Safety Communication issued yesterday, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Another Study Links Popular Heartburn Drugs to Hip Fractures

A new study is providing more evidence of an association between hip fractures in older women and the use of popular heartburn drugs known as proton pump inhibitors (PPIs). The study, published in the British Medical Journal, found that post-menopausal … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Proton Pump Inhibitors Linked to Heart Birth Defects

Proton Pump Inhibitors (PPIs) have been being linked to heart birth defects, when taken by women in the first trimester of pregnancy, according to a recent study. Popular PPIs include Aciphex (rabeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Prilosec (omeprazole), and Protonix … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Studies Show Many People Taking Proton Pump Inhibitors Don’t Need Them

Aciphex, Dexilant, Nexium, Prevacid, Prilosec, and Protonix, all part of a class of drugs known a < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">proton pump inhibitors, may be overprescribed, some recent studies indicate. According to a report from Web MD, overuse of proton pump inhibitors, which … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

New Study Finds PPIs Increase Risk For C. Diff

Popular heartburn medications, < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton Pump Inhibitors (PPIs), have been linked to more adverse reactions; this time, Clostridium difficile (C. diff), in a large Japanese study presented at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. We recently wrote … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.